Our R&D team presented our most recent progress at the annual Biofilms conference in Malmö

We are happy to announce that the European Patent Office has validated our patent as a Unitary Patent, which protects our intellectual property in 17 EU member states and the United Kingdom.

Gintare holds a bachelors degree in Pharmaceutical Sciences from Utrecht University and a masters degree in Chemical Biology from Uppsala University. She has experience in a wide range of areas such as molecular recognition, drug design and NMR spectroscopy.

Ewa holds a bachelor degree in Chemistry and forensic toxicology. She is currently completing her master's degree in Chemistry with a specialization in Radiogenomics, which has enabled her to expand her knowledge in innovative healthcare solutions. In her ongoing master's thesis, she focuses on the development and improvement of radiopharmaceuticals. She has experience in creating voltammetric sensors for microplastic detection.

Sustainability Category

Award Motivation: Alice is a recipient of the Under 35 Changemaker Award 2024 for her dedication to sustainability, demonstrated through her leadership in developing reusable diagnostics to reduce healthcare waste, thereby advancing environmental conservation and resource efficiency in the medical field.

Welcoming Mark Sullivan to our Scientific Advisory Board 👨‍🔬
Mark has extensive experience in the research area of interest, having developed highly sensitive synthetic affinity reagents for different biomarkers such as Covid-19 and steroids.

"I am excited to have the opportunity to support Pharmista Technologies in their endeavour to develop rapid, sensitive and reusable diagnostic tools fit for tracking various biomarkers. The invention put forward will have a significant impact in multiple areas while offering important progress in biological, environmental and clinical monitoring where new multi-functional and reusable materials are desperately needed"

We are excited to announce that Pharmista is one of the companies selected for BioInnovation Institute's Venture Lab program alongside 11 other pioneering companies! This one-year program supports early-stage companies in business development, scientific advancement and team development and includes financial support in terms of a convertible loan of € 500’000 🚀

Robert Porter, Pharmista’s co-founder, share his thoughts on the need for direction and investments in the diagnostics sector.

Each year, Hello Tomorrow selects Deep Tech Pioneers for their annual start-up conference in Paris with the ambition of connecting disruptive innovations with frontiers in the field. Pharmista was selected among 4000+ applicants

More than 200, EU-funded companies applied to the Innovation Radar Summit 2023. Following an initial scan, 36 were selected to compete for a pitching spot at the event. These finalists then participated in an online open voting, which was weighed against the judgment of outside evaluators and experts in the field. 36 was narrowed down to 12, and out of these companies, Pharmista was announced the winner of the publics vote 🎉🎉

We are happy to welcome Radvile Zubryté to the team as our CTO! She has been working on the project for the last 1,5 years and has gained extensive experience around the utilization of SARs in reusable sensors for pregnancy testing. We are thrilled to have her on board full time to work together towards Pharmista’s vision.

Time to Raise is a program designed to assist female founded companies in raising capital. The program invites investors, KOL’s and other mentors to provide guidance and training to maximize the likelihood of raising capital and connect with potential investors.

For the seventh year in a row, Dagens Industri highlights female-led companies at their annual Female Founders event. This year, Alice was selected as one of the finalists alongside six other founders from a selection of 70 applications and got to pitch in front of the crowd.

The EPO has approved Pharmistas European patent application for “A REUSABLE TEST DEVICE” following our successful PCT application. The recognition from the EPO signifies a breakthrough achievement in the field of reusable in vitro diagnostics and underscores the novelty of Pharmista’s reusable platform technology.

Pharmista is one of the eight top finalists of the inaugural Life Science startup competition at TechBBQ.

TechBBQ, once a simple BBQ for tech enthusiasts, is now Scandinavia’s key startup summit, drawing 7,500+ global attendees. The Life Sciences Startup Competition, backed by Novo Nordisk Foundation and presented by XTC at techBBQ, will feature the top eight finalists pitches.

We are exited to celebrate Bhavika Dhar’s recent graduation with an MSc in integrated product design from TU Delft - Industrial Design Engineering.

Bhavikas thesis focused on elevating the pregnancy detection experience, using Pharmista’s technology and product as a case study. Witnessing her design concepts evolve and learning how design can overcome technical barriers has been truly helpful for our future developments.

We’re thrilled to announce that Pharmista has received this years’s grant from Sten K Johnsons Stiftelse in the Technology category, recognizing initiatives at the forefront of technological advancements with broad societal benefits.

We’re exited to introduce Annette Säfholm as the new chairman of the board!

Annette is the driving force behind Gedea Biotech AB which are developing an antibiotic-free vaginal tablet for treating and preventing vaginal infections. Her expertise will be a perfect fit in leveraging the potential of our patented platform technology.

Pharmista receives an International Preliminary Report on Patentability (IPRP) from the EPO concerning Pharmista’s PCT application, acknowledging patentability of claims

We are happy to be one of the selected companies for the WomenTechEU grant of €75'000, supporting early-stage female led companies in deeptech. The grant is financed by the European Innovation Council and SMEs Executive Agency (EISMEA) and will help us to improve our reusable detection technology and push the business forward!

SwedenBIO is the national non-profit association for the life science industry in Sweden, with more than 300 members.